Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorUnsoy, Gozde
dc.contributor.authorKhodadust, Rouhollah
dc.contributor.authorYalcin, Serap
dc.contributor.authorMutlu, Pelin
dc.contributor.authorGunduz, Ufuk
dc.date.accessioned2019-11-24T20:59:02Z
dc.date.available2019-11-24T20:59:02Z
dc.date.issued2014
dc.identifier.issn0928-0987
dc.identifier.issn1879-0720
dc.identifier.urihttps://dx.doi.org/10.1016/j.ejps.2014.05.021
dc.identifier.urihttps://hdl.handle.net/20.500.12513/3203
dc.descriptionWOS: 000340301500028en_US
dc.descriptionPubMed ID: 24931189en_US
dc.description.abstractTargeted drug delivery is a promising alternative to overcome the limitations of classical chemotherapy. In an ideal targeted drug delivery system carrier nanoparticles would be directed to the tumor tissue and selectively release therapeutic molecules. As a novel approach, chitosan coated magnetic nanoparticles (CS MNPs) maintain a pH dependent drug delivery which provides targeting of drugs to the tumor site under a magnetic field. Among various materials, chitosan has a great importance as a pH sensitive, natural, biodegradable, biocompatible and bioadhesive polymer. The aim of this study was to obtain an effective targeted delivery system for Doxorubicin, using chitosan coated MNPs. Different sized CS MNPs were produced by in situ synthesis method. The anti-cancer agent Doxorubicin was loaded onto CS MNPs which were characterized previously. Doxorubicin loading was confirmed by FTIR. Drug loading and release characteristics, and stability of the nanoparticles were investigated. Our results showed that the CS MNPs have pH responsive release characteristics. The cellular internalization of Doxorubicin loaded CS MNPs were visualized by fluorescent microscopy. Doxorubicin loaded CS MNPs are efficiently taken up by MCF-7 (MCF-7/S) and Doxorubicin resistant MCF-7 (MCF-7/1 mu M) breast cancer cells, which increases the efficacy of drug and also maintains overcoming the resistance of Doxorubicin in MCF-7/Dox cells. Consequently, CS MNPs synthesized at various sizes can be effectively used for the pH dependent release of Doxorubicin in cancer cells. Results of this study can provide new insights in the development of pH responsive targeted drug delivery systems to overcome the side effects of conventional chemotherapy. (C) 2014 Elsevier B.V. All rights reserved.en_US
dc.language.isoengen_US
dc.publisherELSEVIER SCIENCE BVen_US
dc.relation.isversionof10.1016/j.ejps.2014.05.021en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectTargeted drug deliveryen_US
dc.subjectDoxorubicinen_US
dc.subjectChitosanen_US
dc.subjectMagnetic nanoparticlesen_US
dc.titleSynthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug deliveryen_US
dc.typearticleen_US
dc.relation.journalEUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCESen_US
dc.contributor.departmentKırşehir Ahi Evran Üniversitesi, Mühendislik-Mimarlık Fakültesi, Gıda Mühendisliği Bölümüen_US
dc.identifier.volume62en_US
dc.identifier.startpage243en_US
dc.identifier.endpage250en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster